Latest filing published 24 Jun 2025 for uniQure N.V., €27k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +67.4%Entry US$52.40 · Close at T+365 US$87.70
- -28.1%Entry US$98.90 · Close at T+365 US$71.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jeremy P. Springhorn: trading record in brief
This profile gathers the share dealings of Jeremy P. Springhorn across 2 companies, led by uniQure N.V. and Syros Pharmaceuticals, Inc. In total, 22 filings cover trades dated from 15 December 2017 to 20 June 2025.
Market trades split into 3 purchases (€206k) and 9 sales (€187k). Purchases outweigh sales by €19k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 10 share grants. 2025 to date brings no purchases and 1 sale.
Half of the purchases are above €46k and half below. On 1 out of 3 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +48.1%. They describe history only and say nothing certain about the share price ahead.
The newest entry dates from 24 June 2025: an open-market sale of €27k, in uniQure N.V. The last insider purchase was made public on 12 November 2019, 2,554 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jeremy P. Springhorn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,112 shares@ US$14.4536.3% of flowOrdinary SharesSEC:0000904454-25-000340:0
- 7,970 shares0Ordinary SharesSEC:0000904454-25-000307:0
- 8,080 shares0Ordinary SharesSEC:0000904454-24-000405:0
- 2,231 shares@ US$5.1239.3% of flowOrdinary SharesSEC:0000904454-24-000375:0
- 2,286 shares@ US$18.8816.8% of flowOrdinary SharesSEC:0000904454-23-000386:1
- 8,700 shares0Ordinary SharesSEC:0000904454-23-000386:0
- 384 shares@ US$20.4127.4% of flowOrdinary SharesSEC:0000899243-23-006578:0
- 9,080 shares0Ordinary SharesSEC:0000904454-22-000350:0
- 602 shares@ US$16.7033.2% of flowOrdinary SharesSEC:0000904454-22-000217:0
- 1,534 shares0Ordinary SharesSEC:0000904454-22-000195:0
- 505 shares@ US$37.508.1% of flowOrdinary SharesSEC:0000904454-21-000286:0
- 2,382 shares0Ordinary SharesSEC:0000904454-21-000256:0
- 2,063 shares0Ordinary SharesSEC:0000904454-20-000265:0
- 4 shares@ US$60.940.1% of flowOrdinary SharesSEC:0000904454-20-000108:0
- 803 shares@ US$62.2025.3% of flowOrdinary SharesSEC:0000904454-20-000108:1
- 9,879 shares@ US$4.9950.1% of flowCommon StockSEC:0001209191-19-056026:0Canonical exit: 9 Feb 2020 (T+90)
- 10,121 shares@ US$4.9749.9% of flowCommon StockSEC:0001209191-19-056026:1Canonical exit: 10 Feb 2020 (T+90)
- 87,000 shares0Common StockSEC:0001209191-19-010291:0
- 1,210 shares@ US$31.3218.6% of flowOrdinary SharesSEC:0000904454-19-000118:0
- 3,230 shares0Ordinary SharesSEC:0000904454-19-000113:0
- 4,792 shares0Ordinary SharesSEC:0000904454-18-000080:0
- 15,000 shares@ US$9.0846.1% of flowCommon StockSEC:0001179110-17-015427:0Canonical exit: 15 Mar 2018 (T+90)
22 of 22 declarations
